GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $7,959,000 | +19.2% | 182,831 | +19.2% | 0.10% | +37.0% |
| Q1 2022 | $6,679,000 | +0.7% | 153,331 | +2.0% | 0.07% | +2.8% |
| Q4 2021 | $6,633,000 | +13.9% | 150,397 | -1.3% | 0.07% | +4.4% |
| Q3 2021 | $5,822,000 | -14.4% | 152,372 | -10.8% | 0.07% | -15.0% |
| Q2 2021 | $6,802,000 | -14.3% | 170,820 | -23.1% | 0.08% | -20.8% |
| Q1 2021 | $7,933,000 | +6.1% | 222,269 | +9.5% | 0.10% | -11.4% |
| Q4 2020 | $7,479,000 | -10.5% | 203,025 | -8.6% | 0.11% | -21.4% |
| Q3 2020 | $8,358,000 | -9.8% | 222,063 | -2.3% | 0.14% | -16.2% |
| Q2 2020 | $9,268,000 | -6.5% | 227,220 | -13.2% | 0.17% | -10.4% |
| Q1 2020 | $9,908,000 | -12.6% | 261,786 | +8.5% | 0.19% | +5.5% |
| Q4 2019 | $11,334,000 | +12.0% | 241,170 | +1.7% | 0.18% | +1.1% |
| Q3 2019 | $10,119,000 | +6.3% | 237,089 | -0.3% | 0.18% | +2.3% |
| Q2 2019 | $9,517,000 | -0.4% | 237,804 | +3.1% | 0.18% | +7.9% |
| Q1 2019 | $9,560,000 | +14.3% | 230,561 | +5.3% | 0.16% | +0.6% |
| Q4 2018 | $8,367,000 | -17.5% | 218,966 | -13.3% | 0.16% | -9.9% |
| Q3 2018 | $10,147,000 | +46.5% | 252,604 | +47.0% | 0.18% | +33.1% |
| Q2 2018 | $6,926,000 | +7.9% | 171,827 | +4.6% | 0.14% | +2.3% |
| Q1 2018 | $6,420,000 | +17.0% | 164,327 | +6.3% | 0.13% | +15.7% |
| Q4 2017 | $5,485,000 | -19.2% | 154,648 | -7.5% | 0.12% | -13.5% |
| Q3 2017 | $6,786,000 | -6.1% | 167,154 | -0.3% | 0.13% | -18.4% |
| Q2 2017 | $7,228,000 | +2.1% | 167,648 | -0.2% | 0.16% | -5.2% |
| Q1 2017 | $7,079,000 | -13.7% | 167,922 | -21.2% | 0.17% | -7.5% |
| Q4 2016 | $8,204,000 | +5.2% | 213,179 | +17.8% | 0.19% | -4.1% |
| Q3 2016 | $7,798,000 | +28.0% | 180,904 | +28.6% | 0.19% | +8.4% |
| Q2 2016 | $6,094,000 | +33.9% | 140,699 | +25.2% | 0.18% | +26.1% |
| Q1 2016 | $4,552,000 | -13.8% | 112,343 | -14.2% | 0.14% | -17.4% |
| Q4 2015 | $5,280,000 | +4.9% | 130,896 | -0.0% | 0.17% | -2.3% |
| Q3 2015 | $5,031,000 | -0.3% | 130,919 | +8.0% | 0.18% | +6.0% |
| Q2 2015 | $5,048,000 | +68.3% | 121,257 | +86.4% | 0.17% | +69.4% |
| Q1 2015 | $2,999,000 | +34.5% | 65,053 | +24.4% | 0.10% | +34.2% |
| Q4 2014 | $2,230,000 | +24.9% | 52,274 | +34.3% | 0.07% | +19.7% |
| Q3 2014 | $1,786,000 | -13.5% | 38,933 | +0.7% | 0.06% | -12.9% |
| Q2 2014 | $2,064,000 | +5.4% | 38,671 | +5.3% | 0.07% | 0.0% |
| Q1 2014 | $1,959,000 | -1.0% | 36,734 | -1.1% | 0.07% | -5.4% |
| Q4 2013 | $1,979,000 | +21.1% | 37,138 | +13.8% | 0.07% | 0.0% |
| Q3 2013 | $1,634,000 | +4.3% | 32,621 | +3.8% | 0.07% | -2.6% |
| Q2 2013 | $1,567,000 | – | 31,423 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |